GRUENDELPARTNER advises Eckert & Ziegler BEBIG on the acquisition of WOLF-Medizintechnik

Euronext-listed Eckert & Ziegler BEBIG which is active in the medical devices segment of the healthcare industry, has acquired St. Gangloff (Thuringia, Germany) based WOLF-Medizintechnik GmbH.

WOLF-Medizintechnik is a producer of X-ray therapy units for the treatment of skin surface tumours as well as joint disorders.

The core business of Eckert & Ziegler BEBIG, located in Seneffe (Belgium), is the production and distribution of brachytherapy products for the treatment of cancer. Eckert & Ziegler BEBIG employs over 130 staff members worldwide.

A team of GRUENDELPARTNER headed by Dr. Steffen Fritzsche together with in-house counsel Michael Schmolinske has provided legal support throughout the transaction process including due diligence and negotiations. The transaction team of GRUENDELPARTNER has supported the Eckert & Ziegler Group in the past with regard to capital measures and strategic transactions.

    Dr. Steffen Fritzsche (Lead, Corporate, based in Berlin),
    Anja Bayer, Denis Koudous (both Commercial and based in Leipzig)
  • In-house:
    Michael Schmolinske, LL.M.

Contact us:
Mädler-Passage, Grimmaische Str. 2-4
04109 Leipzig
Tel.: +49 341 231062-0
Fax: +49 341 231062-30
Email: ed.re1521685347ntrap1521685347ledne1521685347urg@g1521685347izpie1521685347l1521685347